Author Page for Xia Zhang

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Higher versus Standard Starting Dose of Insulin Glargine 100 U/mL in Overweight or Obese Chinese Patients with Type 2 Diabetes: Results of a Multicentre, Open-Label, Randomised Controlled Trial (BEYOND VII)

Number of pages: 40 Posted: 21 Aug 2019

Linong Ji, Hailong Wan, Binhong Wen, Xueying Wang, Junfen Wang, Rongwen Bian, Wuyan Pang, Jian Tian, Yan Wang, Fang Bian, Zhengnan Gao, Alex Condoleon, Wei Feng, Xia Zhang and Nan Cui

Peking University - Department of Endocrinology and Metabolism, Panjin Central Hospital, Government of the People's Republic of China - People's Hospital of Liaoning Province, Jinzhou Central Hospital, Second Hospital of Shijiazhuang, Jiangsu Province Institute of Geriatrics, Henan University - Huaihe Hospital, Shenyang Medical College, Second Hospital of Chaoyang City, Government of the People's Republic of China - Cangzhou People's Hospital, Dalian University - Dalian Municipal Central Hospital, Sanofi - France, Sanofi - Shanghai, Sanofi - Shanghai and Sanofi - Shanghai

Downloads 114 (527,202)

Xia Zhang

Sanofi - Shanghai

1

114

0

Scholarly Papers (1)

Higher versus Standard Starting Dose of Insulin Glargine 100 U/mL in Overweight or Obese Chinese Patients with Type 2 Diabetes: Results of a Multicentre, Open-Label, Randomised Controlled Trial (BEYOND VII)

Abstract: